Publicaciones destacadas

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

Gaig, Carles; Compta, Yaroslau; Heidbreder, Anna; Marti, Maria J; Titulaer, Maarten J;

(...)

Sabater, Lidia; Iranzo, Alex; Cano, Joan Santamaria; Dalmau, Josep; Graus, Francesc.

Referencia:
Neurology 2021.
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2

Landa, Jon; Guasp, Mar; Miguez-Cabello, Federico; Guimaraes, Joana; Mishima, Takayasu;

(...)

Gasull, Xavier; Soto, David; Graus, Francesc; Sabater, Lidia; Dalmau, Josep.

Referencia:
Annals Of Neurology 2021.
Placental transfer of NMDAR antibodies causes reversible alterations in mice

Garcia-Serra, Anna; Radosevic, Marija; Pupak, Anika; Brito, Veronica; Rios, Jose;

(...)

Pedreno, Marta; Joubert, Bastien; Gines, Silvia; Planaguma, Jesus; Dalmau, Josep.

Referencia:
Neurology-Neuroimmunology & Neuroinflammation 2021.
Sleep disorders in autoimmune encephalitis

Munoz-Lopetegi, Amaia; Graus, Francesc; Dalmau, Josep; Santamaria, Joan;

Referencia:
Lancet Neurology 2020.
Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis

Spatola, Marianna; Pedrol, Mar Petit; Maudes, Estibaliz; Simabukuro, Mateus; Muniz-Castrillo, Sergio;

(...)

Smitt, Peter Sillevis; Honnorat, Jerome; Rosenfeld, Myrna R; Graus, Francesc; Dalmau, Josep.

Referencia:
Neurology 2020.
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis

Mannara, Francesco; Radosevic, Marija; Planaguma, Jesus; Soto, David; Aguilar, Esther;

(...)

Quirk, Michael; Dai, Jing; Gasul, Xavier; Lewis, Mike; Dalmau, Josep.

Referencia:
Brain 2020.
Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia

Stein, Heike; Barbosa, Joao; Rosa-Justicia, Mireia; Prades, Laia; Morato, Alba;

(...)

Arino, Helena; Martinez-Hernandez, Eugenia; Castro-Fornieles, Josefina; Dalmau, Josep; Compte, Albert.

Referencia:
Nature Communications 2020.
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Armangue, T; Olivé-Cirera, G; Martínez-Hernandez, E; Sepulveda, M; Muñoz-Batista, M;

(...)

Arrambide, G; Tintoré, M; Montalban, X; Auger, C; Vanderver, A.

Referencia:
Lancet Neurology 2020.